{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:16:02Z","timestamp":1782623762478,"version":"3.54.5"},"reference-count":22,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Polycystic ovary syndrome (PCOS)-related infertility remains a major challenge and the efficacy of conventional treatments is limited in certain patient groups and often fails to address the underlying causes of ovarian dysfunction. Platelet-rich plasma (PRP) is rich in growth factors and cytokines and has emerged as a potential regenerative therapy for women with a diminished ovarian reserve. Methods: A literature search for studies pertaining to intraovarian PRP administration and PCOS was performed on PubMed. Results: Preclinical studies in PCOS animal models have demonstrated that intraovarian PRP can improve folliculogenesis, enhance antioxidant defenses, normalize steroid hormone levels, and downregulate pro-apoptotic pathways. Early clinical reports suggest that intraovarian PRP may restore ovulation and improve ovarian reserve in women with long-standing amenorrhea and poor responses to standard fertility treatments. The proposed mechanisms of how PRP could improve folliculogenesis include the modulation of local ovarian gene expression, the activation of dormant follicles, angiogenesis, and a reduction in oxidative stress and inflammation. Conclusions: Although preliminary data are promising, larger studies are needed to establish the efficacy, if any, of intraovarian PRP administration as a potential novel therapeutic adjunct in women with PCOS.<\/jats:p>","DOI":"10.3390\/jcm14248845","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:57:24Z","timestamp":1765879044000},"page":"8845","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intraovarian Platelet-Rich Plasma Therapy for PCOS: Unanswered Questions and Future Research Directions"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7952-1428","authenticated-orcid":false,"given":"Zaher","family":"Merhi","sequence":"first","affiliation":[{"name":"Reproductive Endocrinology and Infertility, Rejuvenating Fertility Center, New York, NY 10019, USA"},{"name":"Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Maimonides Medical Center, Brooklyn, NY 11219, USA"},{"name":"Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Albert Einstein College of Medicine, Bronx, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Singh, S., Pal, N., Shubham, S., Sarma, D.K., Verma, V., Marotta, F., and Kumar, M. (2023). Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041454"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0889-8529(05)70286-3","article-title":"Polycystic ovary syndrome","volume":"26","author":"Goudas","year":"1997","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tem.2019.01.005","article-title":"Implications and Future Perspectives of AGEs in PCOS Pathophysiology","volume":"30","author":"Merhi","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbrc.2023.08.004","article-title":"PAK2\/beta-catenin\/c-Myc\/PKM2 signal transduction suppresses ovarian granulosa cell apoptosis in polycystic ovary syndrome","volume":"677","author":"Hui","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Xu, Y., Zhang, Z., Wang, R., Xue, S., Ying, Q., and Jin, L. (2024). Roles of estrogen and its receptors in polycystic ovary syndrome. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1395331"},{"key":"ref_6","first-page":"30","article-title":"The Efficiency of Introducing Intrauterine Infusion of Autologous Platelet-Rich Plasma versus Granulocyte Colony-Stimulating Factor in Repeated Implantation Failure Patients: An Unblinded Randomised Clinical Trial","volume":"18","author":"Mehrafza","year":"2024","journal-title":"Int. J. Fertil. Steril."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s43032-021-00579-2","article-title":"Use of Intra-uterine Injection of Platelet-rich Plasma (PRP) for Endometrial Receptivity and Thickness: A Literature Review of the Mechanisms of Action","volume":"28","author":"Mouanness","year":"2021","journal-title":"Reprod. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/19396368.2020.1862357","article-title":"An update on platelet-rich plasma (PRP) therapy in endometrium and ovary related infertilities: Clinical and molecular aspects","volume":"67","author":"Hajipour","year":"2021","journal-title":"Syst. Biol. Reprod. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1080\/15376516.2022.2057264","article-title":"The protective effect of co-administration of platelet-rich plasma (PRP) and pentoxifylline (PTX) on cyclophosphamide-induced premature ovarian failure in mature and immature rats","volume":"32","author":"Aboutalebi","year":"2022","journal-title":"Toxicol. Mech. Methods"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/08977190600821327","article-title":"Platelet-rich plasma preparation using three devices: Implications for platelet activation and platelet growth factor release","volume":"24","author":"Everts","year":"2006","journal-title":"Growth Factors"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3858\/emm.2012.44.5.037","article-title":"Platelet-rich plasma inhibits the apoptosis of highly adipogenic homogeneous preadipocytes in an in vitro culture system","volume":"44","author":"Fukaya","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"ref_12","first-page":"243","article-title":"Preliminary Findings of Platelet-Rich Plasma-Induced Ameliorative Effect on Polycystic Ovarian Syndrome","volume":"21","author":"Dehgan","year":"2019","journal-title":"Cell J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11892-024-01539-1","article-title":"Metformin: Past, Present, and Future","volume":"24","author":"Chaudhary","year":"2024","journal-title":"Curr. Diabetes Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: An analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41585-023-00787-2","article-title":"Body fluid-derived stem cells\u2014An untapped stem cell source in genitourinary regeneration","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12929-024-01085-8","article-title":"Secretome from estrogen-responding human placenta-derived mesenchymal stem cells rescues ovarian function and circadian rhythm in mice with cyclophosphamide-induced primary ovarian insufficiency","volume":"31","author":"Le","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10815-021-02385-w","article-title":"Ovarian response to intraovarian platelet-rich plasma (PRP) administration: Hypotheses and potential mechanisms of action","volume":"39","author":"Seckin","year":"2022","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s43032-025-01791-0","article-title":"Ameliorative Effect of Combined Placenta-Derived Mesenchymal Stem Cells plus Platelet-rich Plasma on Polycystic Ovarian Model in Rats: A Biochemical and Histological Study","volume":"32","author":"Sarvestani","year":"2025","journal-title":"Reprod. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"bqae023","DOI":"10.1210\/endocr\/bqae023","article-title":"Disturbed Follicular Microenvironment in Polycystic Ovary Syndrome: Relationship to Oocyte Quality and Infertility","volume":"165","author":"Dai","year":"2024","journal-title":"Endocrinology"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Guo, W., Zheng, X., Zheng, D., Yang, Z., Yang, S., Yang, R., Li, R., and Qiao, J. (2023). Effectiveness, Flexibility and Safety of Switching IVF to IVM as a Rescue Strategy in Unexpected Poor Ovarian Response for PCOS Infertility Patients. J. Clin. Med., 12.","DOI":"10.3390\/jcm12051978"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S1015","DOI":"10.4103\/jpbs.jpbs_166_25","article-title":"Exploring Intraovarian Platelet-Rich Plasma (PRP) Therapy: A New Hope for Polycystic Ovary Syndrome (PCOS) Patients","volume":"17","author":"Chaudhary","year":"2025","journal-title":"J. Pharm. Bioallied Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"luad038","DOI":"10.1210\/jcemcr\/luad038","article-title":"Intraovarian Platelet-rich Plasma Administration Induced Spontaneous Ovulation in an Anovulatory Woman with PCOS","volume":"1","author":"Merhi","year":"2023","journal-title":"JCEM Case Rep."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/24\/8845\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T10:12:39Z","timestamp":1765879959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/24\/8845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":22,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["jcm14248845"],"URL":"https:\/\/doi.org\/10.3390\/jcm14248845","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,14]]}}}